Bliss GVS Pharma's Managing Director Gagan Harsh Sharma Steps Down
Gagan Harsh Sharma, Managing Director of Bliss GVS Pharma Limited, has resigned effective November 6, 2025, citing other professional commitments. He will also step down from various committee positions and directorships in subsidiary companies. The Board approved unaudited financial results for Q2 and H1 2025, and appointed Shreekrushna Joshi as Head – Legal and Senior Management Personnel.
*this image is generated using AI for illustrative purposes only.
Bliss GVS Pharma Limited, a prominent player in the pharmaceutical industry, announced a significant change in its leadership. The company's Managing Director, Gagan Harsh Sharma (DIN: 07939421), has resigned from his position, effective immediately from November 6, 2025.
Resignation Details
The Board of Directors of Bliss GVS Pharma Limited convened a meeting at the company's registered office on November 6, 2025, where they accepted Mr. Sharma's resignation. Mr. Sharma cited other professional commitments as the reason for his departure.
Impact on Company Positions
As a result of his resignation, Mr. Sharma will also step down from several key positions within the company:
| Position | Committee |
|---|---|
| Member | Audit Committee |
| Member | Corporate Social Responsibility Committee |
| Member | Risk Management Committee |
Additionally, Mr. Sharma has relinquished his directorship roles in the following subsidiary and associate companies:
- Kremoint Pharma Pvt. Ltd.
- Bliss GVS International Pte Ltd (Singapore)
- Asterisk Life Sciences Ghana Ltd
- EPII Exports Pvt. Ltd.
- Asterisk Lifesciences GB Limited (UK)
Family Connections
Mr. Sharma has familial ties within the company's leadership:
- Spouse of Dr. Vibha Sharma, Whole-Time Director
- Brother-in-law of Mrs. Shruti Vishal Rao, also a Whole-Time Director
Other Board Decisions
In the same board meeting, which lasted from 4:30 PM to 6:10 PM, the company also:
- Approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025
- Appointed Mr. Shreekrushna Joshi as Head – Legal and Senior Management Personnel, effective from November 6, 2025
The company has informed the National Stock Exchange of India Ltd. and BSE Limited about these developments, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
As Bliss GVS Pharma Limited navigates this transition in leadership, stakeholders will be observing how these changes may impact the company's future direction and performance in the pharmaceutical sector.
Historical Stock Returns for Bliss GVS Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.26% | +3.19% | -5.05% | +39.22% | +87.49% | +102.95% |
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
